Over 450 Total Lots Up For Auction at Three Locations - CO 05/12, PA 05/15, NY 05/20

ACGT awards $1.3 million to scientists working to cure glioblastoma, sarcoma and ovarian cancer

Press releases may be edited for formatting or style | October 18, 2017 Rad Oncology

Daniel Powell, Jr., PhD -- Immunotherapy for Ovarian Cancer
Director of Immunotherapy for Division of Gynecology

University of Pennsylvania Perelman School of Medicine
stats
DOTmed text ad

Your Trusted Source for Sony Medical Displays, Printers & More!

Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.

stats
Dr. Powell's research focuses on the development of innovative immunotherapeutic strategies, including adoptive immunotherapy, using chimeric antigen receptor (CAR) T cells. Dr. Powell will used his ACGT grant to enroll nine ovarian cancer patients in a new clinical trial. Immune system killer T cells will be developed outside the body and reinserted to establish an offense against the disease and a defense against recurrence.

"ACGT's Clinical Investigator grants allow these scientists to advance their research from the laboratory to the bedside for patients in clinical trials, providing for an opportunity to see these treatments work in actual patients and hopefully save lives," noted Walter. "Our goal at ACGT is to truly make an impact on how cancer is treated through the use of gene and cell therapies so that one day, cancer will be a treatable and manageable disease."

Back to HCB News

You Must Be Logged In To Post A Comment